vimarsana.com
Home
Live Updates
BioMarin Announces Governance Enhancements and Value Creatio
BioMarin Announces Governance Enhancements and Value Creatio
BioMarin Announces Governance Enhancements and Value Creation Initiatives
/PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN), a global biotechnology company dedicated to transforming lives through genetic discovery, today...
Related Keywords
Indiana ,
United States ,
Indiana University ,
Northeastern University ,
Massachusetts ,
California ,
Boston ,
American ,
Alexander Hardy ,
Iovance Biotherapeutics ,
Traci Mccarty ,
Eli Lilly ,
Athena Countouriotis ,
Barbara Bodem ,
Richarda Meier ,
Los Angeles ,
Marc Steinberg ,
Mark Enyedy ,
Marni Kottle ,
Daiichi Sankyo ,
Pfizer ,
Nasdaq ,
Prnewswire Biomarin Pharmaceutical Inc ,
University Of California ,
Biotechnology Innovation Organization ,
Bristol Myers Squibb ,
Pediatric Hematology Oncology Program ,
Fred Hutchinson Cancer Research Center ,
Jones Day ,
Enovis Corporation ,
Harvard Law School ,
Dentsply Sirona Inc ,
Company Establishes Strategic ,
Financial Analyst For Irwin Management Company ,
Biomarin Pharmaceutical Inc ,
Jp Morgan Securities ,
American Cancer Society Of Eastern New England ,
Head Of Corporate Development ,
Exchange Commission ,
Goldman Sachs ,
Invacare Corporation ,
Genzyme Corporation ,
Tufts University School Of Medicine ,
Committee Of The Board ,
Syneos Health ,
Mallinckrodt Pharmaceuticals ,
Board Approves Appointment ,
Three New Independent ,
Establishes Strategic ,
Operating Review Committee ,
Marin Enters ,
Information Sharing Agreements ,
Marin Pharmaceutical ,
Operating Review ,
Biomarin Board ,
Elliott Investment Management ,
Cooperation Agreement ,
Senior Portfolio Manager Marc Steinberg ,
Nature Conservancy ,
Interim Chief Financial Officer ,
Senior Vice President ,
Chief Financial Officer ,
Chief Financial ,
Vice President ,
Financial Analyst ,
Tirwin Management ,
Turning Point Therapeutics ,
Chief Executive Officer ,
Chief Medical Officer ,
Adverum Biotechnologies ,
Ambit Biosciences ,
Tufts University School ,
Executive Vice President ,
Corporate Development ,
Proteostasis Therapeutics ,
American Cancer Society ,
Eastern New England ,
Biotechnology Innovation ,
Logicbio Therapeutics ,
Akebia Therapeutics ,
Fate Therapeutics ,
Biomarin Pharmaceutical ,
Quarterly Report ,